S. C. Schimpff

1.0k total citations
18 papers, 498 citations indexed

About

S. C. Schimpff is a scholar working on Pharmacology, Oncology and Infectious Diseases. According to data from OpenAlex, S. C. Schimpff has authored 18 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in S. C. Schimpff's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Neutropenia and Cancer Infections (5 papers) and Antibiotic Resistance in Bacteria (3 papers). S. C. Schimpff is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Neutropenia and Cancer Infections (5 papers) and Antibiotic Resistance in Bacteria (3 papers). S. C. Schimpff collaborates with scholars based in United States, Malaysia and United Kingdom. S. C. Schimpff's co-authors include P. H. Wiernik, George L. Drusano, Carlos A. De Jongh, Kathryn A. Newman, Harold C. Standiford, William L. Hewitt, John Crowley, James C. Wade, Marcia R. Moody and Beverly A. Tatem and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

S. C. Schimpff

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. C. Schimpff United States 11 180 167 131 124 79 18 498
Tattersall Mh Australia 7 306 1.7× 119 0.7× 88 0.7× 69 0.6× 174 2.2× 18 484
B. Lank Canada 9 241 1.3× 89 0.5× 166 1.3× 92 0.7× 105 1.3× 13 419
Davis M. Hahn United States 8 168 0.9× 86 0.5× 77 0.6× 51 0.4× 74 0.9× 9 323
Clarence L. Fortner United States 18 431 2.4× 246 1.5× 209 1.6× 153 1.2× 215 2.7× 30 841
R. D. Foord United States 9 61 0.3× 305 1.8× 118 0.9× 142 1.1× 35 0.4× 15 493
Martin E. Plaut United States 12 49 0.3× 296 1.8× 191 1.5× 78 0.6× 55 0.7× 19 635
K. Sack Germany 13 60 0.3× 143 0.9× 156 1.2× 49 0.4× 33 0.4× 76 620
Y. Valcke Belgium 11 72 0.4× 207 1.2× 205 1.6× 114 0.9× 32 0.4× 23 553
P.P. Sfikakis Greece 16 48 0.3× 189 1.1× 163 1.2× 66 0.5× 24 0.3× 32 806
Susan Raber United States 14 82 0.5× 283 1.7× 168 1.3× 99 0.8× 51 0.6× 33 628

Countries citing papers authored by S. C. Schimpff

Since Specialization
Citations

This map shows the geographic impact of S. C. Schimpff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. C. Schimpff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. C. Schimpff more than expected).

Fields of papers citing papers by S. C. Schimpff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. C. Schimpff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. C. Schimpff. The network helps show where S. C. Schimpff may publish in the future.

Co-authorship network of co-authors of S. C. Schimpff

This figure shows the co-authorship network connecting the top 25 collaborators of S. C. Schimpff. A scholar is included among the top collaborators of S. C. Schimpff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. C. Schimpff. S. C. Schimpff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Klášterský, Jean, et al.. (1995). Handbook of Supportive Care in Cancer. Melanoma Research. 5(4). 289–289. 14 indexed citations
2.
Schimpff, S. C.. (1993). Infection in Bone Marrow Transplantation: A Model for Examining Predisposing Factors to Infection in Cancer Patients. Recent results in cancer research. 132. 15–34. 2 indexed citations
3.
Newman, Kathryn A. & S. C. Schimpff. (1987). Hospital Hotel Services as Risk Factors for Infection Among Immunocompromised Patients. Clinical Infectious Diseases. 9(1). 206–213. 8 indexed citations
4.
Drusano, George L., S. C. Schimpff, Christa E. van der Gaast‐de Jongh, et al.. (1985). Moxalactam and piperacillin: A study of in vitro characteristics and pharmacokinetics in cancer patients. Infection. 13(1). 20–26. 10 indexed citations
5.
Drusano, George L., Patricia Ryan, Harold C. Standiford, Marcia R. Moody, & S. C. Schimpff. (1984). Integration of Selected Pharmacologic and Microbiologic Properties of Three New  -Lactam Antibiotics: A Hypothesis for Rational Comparison. Clinical Infectious Diseases. 6(3). 357–363. 40 indexed citations
6.
Drusano, George L., Harold C. Standiford, Carlos I. Bustamante, et al.. (1984). The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers. European Journal of Clinical Microbiology & Infectious Diseases. 3(5). 468–470. 14 indexed citations
7.
Drusano, George L., Harold C. Standiford, Carlos I. Bustamante, et al.. (1984). Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrobial Agents and Chemotherapy. 26(5). 715–721. 70 indexed citations
8.
Drusano, George L., S. C. Schimpff, & William L. Hewitt. (1984). The Acylampicillins: Mezlocillin, Piperacillin, and Azlocillin. Clinical Infectious Diseases. 6(1). 13–32. 48 indexed citations
9.
Wade, James C., et al.. (1983). Selective Antimicrobial Modulation as Propbylaxis Against Infection During Granulocytopenia: Trimetboprim-Sulfametboxazole vs. Nalidixic Acid. The Journal of Infectious Diseases. 147(4). 624–634. 84 indexed citations
10.
Walsh, Thomas J. & S. C. Schimpff. (1983). Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.. PubMed. 14. 58–63. 6 indexed citations
11.
12.
13.
Schimpff, S. C., et al.. (1979). Inappropriate Antidiuretic Hormone Following Adenine Arabinoside Administration. Antimicrobial Agents and Chemotherapy. 15(1). 142–144. 18 indexed citations
14.
Young, Viola Mae, Margaret J. Morris, Marcia R. Moody, S. C. Schimpff, & Peter H. Wiernik. (1978). An analysis of Group D streptococci recovered from cancer patients. Infection. 6(3). 98–104. 3 indexed citations
15.
Wiernik, P H, S. C. Schimpff, Charles A. Schiffer, et al.. (1976). Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.. PubMed. 60(1). 41–53. 39 indexed citations
16.
Schimpff, S. C., et al.. (1975). LEUKÆMIA AND LYMPHOMA PATIENTS INTERLINKED BY PRIOR SOCIAL CONTACT. The Lancet. 305(7899). 124–129. 34 indexed citations
17.
Silen, William, et al.. (1973). RECTAL ABSCESSES IN CANCER PATIENTS. The Lancet. 301(7802). 553–554. 3 indexed citations
18.
Schimpff, S. C., et al.. (1972). RECTAL ABSCESSES IN CANCER PATIENTS. The Lancet. 300(7782). 844–847. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tattersall Mh Breakdown of academic impact, for papers by B. Lank Breakdown of academic impact, for papers by Davis M. Hahn Breakdown of academic impact, for papers by Clarence L. Fortner Breakdown of academic impact, for papers by R. D. Foord Breakdown of academic impact, for papers by Martin E. Plaut Breakdown of academic impact, for papers by K. Sack Breakdown of academic impact, for papers by Y. Valcke Breakdown of academic impact, for papers by P.P. Sfikakis Breakdown of academic impact, for papers by Susan Raber
Rankless by CCL
2026